...
首页> 外文期刊>Journal of neurosurgical sciences >Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants
【24h】

Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants

机译:新生儿和青年婴幼儿中阿莫西林的人口药代动力学和给药优化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Amoxicillin is widely used to treat bacterial infections in neonates. However, considerable intercenter variability in dosage regimens of antibiotics exists in clinical practice. The pharmacokinetics of amoxicillin has been described in only a few preterm neonates. Thus, we aimed to evaluate the population pharmacokinetics of amoxicillin through a large sample size covering the entire age range of neonates and young infants and to establish evidence-based dosage regimens based on developmental pharmacokinetics-pharmacodynamics. This is a prospective, multicenter, pharmacokinetic study using an opportunistic sampling design. Amoxicillin plasma concentrations were determined using high-performance liquid chromatography. Population pharmacokinetic analysis was performed using NONMEM. A total of 224 pharmacokinetic samples from 187 newborns (postmenstrual age range, 28.4 to 46.3 weeks) were available for analysis. A two-compartment model with first-order elimination was used to describe population pharmacokinetics. Covariate analysis showed that current weight, postnatal age, and gestational age were significant covariates. The final model was further validated for predictive performance in an independent cohort of patients. Monte Carlo simulation demonstrated that for early-onset sepsis, the currently used dosage regimen (25 mg/kg twice daily [BID]) resulted in 99.0% of premature neonates and 87.3% of term neonates achieving the pharmacodynamic target (percent time above MIC), using a MIC breakpoint of 1 mg/liter. For late-onset sepsis, 86.1% of premature neonates treated with 25 mg/kg three times a day (TID) and 79.0% of term neonates receiving 25 mg/kg four times a day (QID) reached the pharmacodynamic target, using a MIC breakpoint of 2 mg/liter. The population pharmacokinetics of amoxicillin was assessed in neonates and young infants. A dosage regimen was established based on developmental pharmacokinetics-pharmacodynamics.
机译:Amoxicillin广泛用于治疗新生儿中的细菌感染。然而,在临床实践中存在相当大的抗生素方案中的相当大的间隔变异性。 Amoxicillin的药代动力学已仅在少数早产新生儿中描述。因此,我们旨在通过覆盖整个新生儿和青少年婴儿的大型样本量来评估阿莫西林的人口药代动力学,并基于发育药代动力学 - 药物动力学建立循证剂量方案。这是一种使用机会主义采样设计的预期,多中心药代动力学研究。使用高效液相色谱法测定阿莫西林血浆浓度。使用非谋区进行人口药代动力学分析。从187名新生儿(后期年龄范围,28.4至46.3周)共有224个药代动力学样品可用于分析。使用一阶消除的双隔室模型来描述人口药代动力学。协变量分析表明,目前的重量,后期和妊娠期都是显着的协变量。进一步验证了最终模型以在独立的患者队列中进行预测性能。 Monte Carlo仿真表明,对于早期开始的败血症,目前使用的剂量方案(每日25毫克/千克)导致99.0%的早产儿和87.3%的术语新生儿达到药物动力学靶(麦克风百分比) ,使用1毫克/升的麦克风断点。对于晚期败血症,86.1%的早产儿每天(TID)和79.0%的新生儿每天服用25mg / kg的79.0%(qid),达到药效动物靶,使用MIC 2毫克/升的断点。在新生儿和年轻婴儿中评估了阿莫西林的人口药代动力学。基于发育药代动力学药物动力学建立了剂量方案。

著录项

  • 来源
    《Journal of neurosurgical sciences》 |2019年第2期|共9页
  • 作者单位

    Shandong Univ Sch Pharmaceut Sci Dept Clin Pharm Jinan Shandong Peoples R China;

    Shandong Univ Sch Pharmaceut Sci Dept Clin Pharm Jinan Shandong Peoples R China;

    Capital Med Univ Beijing Obstet &

    Gynecol Hosp Dept Neonatol Beijing Peoples R China;

    Capital Med Univ Beijing Childrens Hosp Natl Ctr Childrens Hlth Neonatal Intens Care Unit;

    Capital Med Univ Minist Educ Key Lab Major Dis Children Natl Ctr C Beijing Pediat Res Inst;

    Shandong Univ Shandong Prov Qianfoshan Hosp Dept Neonatol Jinan Shandong Peoples R China;

    CHU Rennes Neonatal Intens Care Unit Rennes France;

    Shandong Univ Shandong Prov Qianfoshan Hosp Dept Pharm Jinan Shandong Peoples R China;

    Shandong Univ Sch Pharmaceut Sci Dept Clin Pharm Jinan Shandong Peoples R China;

    Shandong Univ Sch Pharmaceut Sci Dept Clin Pharm Jinan Shandong Peoples R China;

    Hop Robert Debre AP HP Dept Pediat Pharmacol &

    Pharmacogenet Paris France;

    Capital Med Univ Minist Educ Key Lab Major Dis Children Natl Ctr C Beijing Pediat Res Inst;

    Shandong Univ Sch Pharmaceut Sci Dept Clin Pharm Jinan Shandong Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 头部及神经外科学;
  • 关键词

    amoxicillin; dosing optimization; neonates; pharmacokinetics;

    机译:Amoxicillin;给药优化;新生儿;药代动力学;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号